Raghavan Varadarajan is a Professor at the Molecular Biophysics Unit, Indian Institute of Science, Bangalore. He is recognised as an eminent researcher in the area of protein structure, folding and stability.
Professor Varadarajan is a regular contributor to academic forums. He has had over 85
publications in premier science journals such as Science, Nature, PNAS, and Biochemistry,
covering protein structure, stability and immunogen design.

Dr. Andy Rakestraw joins the Scientific Advisory Board of Zumutor as an expert in protein engineering, antibody discovery, and yeast display. Dr. Rakestraw was the Founding Scientist of Celexion LLC where he helped to develop and commercialize a novel yeast display technology and a fully human, non-immune antibody library while completing numerous service and licensing deals before Celexion’s acquisition in 2015. Dr. Rakestraw has also worked as a resident entrepreneur at Flagship Ventures as well as part of the protein engineering team at Codon Devices where he helped to develop new protein therapeutic scaffolds and selection technology. Currently, Dr. Rakestraw is working on novel immune-oncology strategies at Torque Therapeutics.
Dr. Rakestraw received his PhD from the Department of Bioengineering at MIT and his B.S. in Chemical Engineering at The Georgia Institute of Technology.


Dr. Balaji Rao is an accomplished scientist in the field of protein engineering and human embryonic stem cells at North Carolina State University (NCSU). His current work on molecular recognition of protein scaffolds is widely acknowledged. His research in the area of bio-separation through altered protein structure resulted in exciting biotechnology applications development.
Dr Rao graduated in chemical engineering from the Institute for Chemical Technology,
Mumbai, India (formerly UDCT). He completed his Masters and PhD studies from MIT,
Cambridge, USA.


Dr Anurag Rathore is a professor at the Department of Chemical Engineering at Indian Institute of Technology, Delhi. He is also a key consultant at BiotechCMZ, an initiative to create best practices for the commercialisation of therapeutic biotech products.Anurag completed his PhD from Yale University, USA, and worked in the process development groups at Pharmacia Corporation, St. Louis, and at Amgen, Inc., Thousand
Oaks, USA.
He is an active member of the Parenteral Drug Association (PDA) and American Chemical
Society (ACS), with more than 200 publications and presentations in these areas to his
credit. He presently serves as the Editor-in-Chief of Preparative Biochemistry and
Biotechnology and participates in the editorial advisory boards for several international




As an independent director of Zumutor, Patrick Vink provides his valuable advice and guidance in the field of life sciences to the company. He dominates the industry with his vast experience in leadership roles in various organisations. Mr. Vink is currently the Chairman of the Board of PIQUR Therapeutics AG, Non-Executive Board Member of Concordia Healthcare Inc., Non-Executive Chairman of Acacia Pharma Limited and Director of Spero Therapeutics Ltd. His previous work profile is equally impressive; he has spent over three years at Cubist Pharmaceuticals Inc., which he joined in 2012 as Senior Vice-President and Head of International Business Operations, and where afterwards he served as Executive Vice President and Chief Operating Officer. Prior to joining Cubist Pharmaceuticals Inc., Mr. Vink served as Senior Vice-President, Head of Global Institutional and Biologics Business at Mylan Inc., which he joined in 2008, helping
to establish the company’s operations in Switzerland. He has also been associated with Novartis Sandoz and Biogen Inc. under various capacities. Mr. Vink graduated as a medical doctor from the University of Leiden, Netherlands in 1988 and obtained his MBA in 1991 at the University of Rochester.


As the consultant to Zumutor, Aloka Sengupta comes with an immaculate 35 years of experience in biopharmaceutical marketing and business development.Her expertise in brand building and successful track record of game changing deal closures..

Read More


As a consultant for Zumutor, Shridhar provides his valuable advice and guidance in the areas of pharmacology and toxicology.Shridhar also provides insights and contacts to the business development efforts of Zumutor.

Read More